Success Metrics

Clinical Success Rate
80.0%

Based on 8 completed trials

Completion Rate
80%(8/10)
Active Trials
0(0%)
Results Posted
25%(2 trials)
Terminated
2(20%)

Phase Distribution

Ph not_applicable
8
80%
Ph early_phase_1
1
10%
Ph phase_2
1
10%

Phase Distribution

1

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution10 total trials
Early Phase 1First-in-human
1(10.0%)
Phase 2Efficacy & side effects
1(10.0%)
N/ANon-phased studies
8(80.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

80.0%

8 of 10 finished

Non-Completion Rate

20.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Completed(8)
Terminated(2)

Detailed Status

Completed8
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
80.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (10.0%)
Phase 21 (10.0%)
N/A8 (80.0%)

Trials by Status

completed880%
terminated220%

Recent Activity

Clinical Trials (10)

Showing 10 of 10 trials
NCT00003654Not Applicable

Diagnostic Study to Identify Sentinel Lymph Nodes in Women With Stage I or Stage II Breast Cancer

Terminated
NCT00743314Early Phase 1

Single-Photon Emission Computed Tomography, Computed Tomography Lymphoscintigraphy, and Intensity-Modulated Radiation Therapy in Treating Patients Who Have Undergone Surgery for Stage I or Stage II Breast Cancer

Completed
NCT00450723Not Applicable

Thoracoscopic Sentinel Lymph Node Biopsy in Patients With Stage I or Stage II Breast Cancer

Completed
NCT00042926Not Applicable

Diagnostic Trial in Patients Who Are Undergoing Surgery for Early Stage Mouth Cancer

Completed
NCT00012168Not Applicable

Lymphoscintigraphy to Detect Early Metastases in Patients With Cancer of the Mouth or Throat

Completed
NCT01276054Phase 2

Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients.

Terminated
NCT00052676Not Applicable

Technetium Tc 99m Sulfur Colloid and Blue Dye In Detecting Sentinel Lymph Nodes in Patients With Breast Cancer

Completed
NCT00005640Not Applicable

Lymphatic Mapping and Sentinel Lymph Node Biopsy in the Treatment of Colorectal Cancer

Completed
NCT00438477Not Applicable

Injection Methods in Finding the Sentinel Lymph Node During Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Invasive Breast Cancer

Completed
NCT00080860Not Applicable

Sentinel Lymph Node Biopsy and Primary Tumor Gene Expression Profiling in Finding Axillary Lymph Node Metastases in Women Who Have Received Neoadjuvant Therapy for Stage II, Stage III, or Stage IV Breast Cancer

Completed

All 10 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
10